Evidence map›Paper›PMID 34910106›Full record

ArticleThe Journal of experimental medicine2022

B cell-intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice.

Michelle S J Lee, Takeshi Inoue, Wataru Ise, Julia Matsuo-Dapaah, James B Wing, Burcu Temizoz, Kouji Kobiyama, Tomoya Hayashi, Ashwini Patil, Shimon Sakaguchi and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Gammaherpesvirus-mediated repression reveals EWSR1 to be a negative regulator of B cell responses.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Michelle S J LeeDivision of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-2694-0549
Takeshi InoueLaboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-9972-6105
Wataru IseLaboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0003-0457-3386
Julia Matsuo-DapaahDivision of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-7007-6620
James B WingLaboratory of Human Immunology (Single Cell Immunology), Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-3462-1003
Burcu TemizozDivision of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-5189-3529
Kouji KobiyamaDivision of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-5846-4807
Tomoya HayashiDivision of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-3189-6463
Ashwini PatilCombinatics Inc., Tokyo, Japan.ORCID 0000-0002-3353-1970
Shimon SakaguchiLaboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0001-8265-6094
A Katharina SimonThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-4077-7995
Jelena S BezbradicaThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID 0000-0003-1441-1727
Satoru NagatoishiResearch Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-0794-3963
Kouhei TsumotoResearch Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-7643-5164
Jun-Ichiro InoueResearch Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-6389-7036
Shizuo AkiraImmunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0001-7602-9617
Tomohiro KurosakiLaboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan.ORCID 0000-0002-6352-304X
Ken J IshiiDivision of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-6728-3872
Cevayir CobanDivision of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-4467-7799
The University of Tokyo · JPThe University of Osaka · JPUniversity of Oxford · GB

Funding

Medical Research Council MR/W001217/1
6 · The paper itself

Abstract

The germinal center (GC) is a site where somatic hypermutation and clonal selection are coupled for antibody affinity maturation against infections. However, how GCs are formed and regulated is incompletely understood. Here, we identified an unexpected role of Tank-binding kinase-1 (TBK1) as a crucial B cell-intrinsic factor for GC formation. Using immunization and malaria infection models, we show that TBK1-deficient B cells failed to form GC despite normal Tfh cell differentiation, although some malaria-infected B cell-specific TBK1-deficient mice could survive by GC-independent mechanisms. Mechanistically, TBK1 phosphorylation elevates in B cells during GC differentiation and regulates the balance of IRF4/BCL6 expression by limiting CD40 and BCR activation through noncanonical NF-κB and AKTT308 signaling. In the absence of TBK1, CD40 and BCR signaling synergistically enhanced IRF4 expression in Pre-GC, leading to BCL6 suppression, and therefore failed to form GCs. As a result, memory B cells generated from TBK1-deficient B cells fail to confer sterile immunity upon reinfection, suggesting that TBK1 determines B cell fate to promote long-lasting humoral immunity.

Indexed as

Host-Pathogen InteractionsAnimalsBiomarkersB-LymphocytesCD40 AntigensGene Expression RegulationGene Knockdown TechniquesGerminal CenterImmunity, HumoralImmunizationInfectionsMiceProtein Serine-Threonine KinasesReceptors, Antigen, B-CellSignal TransductionT-Lymphocytes, Helper-InducerBiomarkersCD40 AntigensProtein Serine-Threonine KinasesReceptors, Antigen, B-CellTbk1 protein, mouse

Identifiers

PMID34910106
PMCPMC8679780
OpenAlexW4200054170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.